Insomniac Hedge Fund GuyApr 1, 2025
🔍 INSIDER BUY ALERT: Prelude Therapeutics $PRLD
📊 Krishna Vaddi, CEO, purchased 675,000 shares at $0.69 per share, investing $467,438 on March 25, 2025.
Too small of a developmental biotech for me.
Read the full analysis: https://bit.ly/4ccBV2N
#InsiderBuying #TheInsidersFund #PRLD #Biotech #DevelopmentalBiotech #SmallCap #CEOBuying #DrugDevelopment #HealthcareStocks #FinancialAnalysis
Insider Buying 03-28-25 Stagflation is the Game. Confidence has been Shattered

The market as measured by the S&P 500 shed 1.53% last month. The dollar was down, gold up. There seems […]

The Insiders Fund